CPL Business Consultants examined the supply and health-related benefits of xanthohumol, e.g. in therapeutics, inflammation, microbial activation, metabolic syndrome and cognitive impairment. This report was also part of PUReOPE, an EU-funded project, which found opportunities to valorise waste streams from the brewing industry.
Method
The study used numerous sources, which included in-house databases and an extensive contact network. For example, CPL conducted face-to-face and telephone interviews and made contacts at trade shows. Because of this, CPL gained insights that the client could not obtain independently.
Additionally, CPL used publicly available information, e.g. from government agencies, patents, scientific journals and the trade press. Furthermore, data from key industry resources provided sufficient depth for accurate analysis and guidance.
The final report was divided into two parts. Firstly, the summary report provided the essence of CPL’s findings and recommendations. Secondly, the reference report with detailed data and its analysis.
Click to see the contents of the study, or look below for an outline.
Table of Contents
Principal Findings
- PUReOPE Opportunities with Xanthohumol and Related Compounds
- Supply
- Players Products and Patent Applications
- Health-Related Benefits
- Conclusions
- Recommendations
Background
- Aging Related Disease
- XN and Derivatives as an in Vivo Antioxidant
- Xanthohumol benefits
11 Hop Players and Suppliers
- Products and Pricing
Recent Articles and News
- Nematodes and Polyphenols
- 3 Articles
- Microbial and Dietary Activation
- 10 Articles
- Cognitive Impairment
- 8 Articles
- Metabolic Syndrome
- 8 Articles
- Phytoestrogen
- 4 Articles
- Tissue Related Inflammation
- 4 Articles
- Adaptive Inflammation
- 4 Articles
- Therapeutics
- 7 Articles
Patents
4 Tables
6 Figures
Please take a look at our PowerPoint Introduction and Brochure describing deliverables as well as differentiators and case studies. Eight case studies can also be reviewed.